207 — Albuquerque, New Mexico

207 is a clinical research site located in Albuquerque, New Mexico, United States.

Crixeo Clinical Trials Trust Score: 11/100 (FAILING). This profile has not yet been claimed by the site owner.

207 has participated in 2 clinical trials.

Therapeutic areas: Rheumatoid Arthritis.

Sponsors: UCB Pharma SA, UCB Pharma.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Albuquerque

Browse all research sites in New Mexico · View every site in Albuquerque

• University of New Mexico Health Sciences Center
• University of New Mexico Heath Science Center
• University of New Mexico Comprehensive Cancer Center-Clinical Research Office ( Site 0019)
• University of New Mexico Center for Brain Recovery and Repair
• University of New Mexico Addiction and Substance Abuse Program
• University of New Mexico Cancer Research & Treatment Center
• University of New Mexico /ID# 144220
• University of New Mexico Cancer Center
• UNM Hospital
• University of New Mexico Medical Center
• New Mexico Veterans Administration Health Care System
• University of New Mexico Hospital, COVID-19 Research Clinic

Sponsor Feasibility Report

Trust Score: 11/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for 207?

207 has a Crixeo Trust Score of 11/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has 207 conducted?

207 has 2 clinical trials on record. Their work covers Rheumatoid Arthritis.

Is 207 accredited by Crixeo Clinical Trials?

207 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about 207?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.